SUMMARY Immunoreactive plasminogen activators were studied in tissue sections using a peroxidase method and monospecific antibodies to tissue plasminogen activator produced by a melanoma. Tissue plasminogen activator reactivity was found in skin melanomas and in endothelial and smooth muscle cells of arteries and veins. Vessels of the umbilical cord showed higher reactivity than peripheral vessels. Only faint antiurokinase reactivity was found. By means of the fibrin slide technique, fibrinolytic activity could be shown in peripheral vessel walls but not in the umbilical cord, which suggests that immunoreactivity of tissue plasminogen activator bound to an inhibitor can also be demonstrated. This method may be a useful tool in further studies of tissue plasminogen activator in physiological as well as pathological processes.
Plasminogen is converted into plasmin by two naturally occurring plasminogen activators. The so called tissue plasminogen activator (t-PA) is probably synthesised and released from the vessel wall into the blood stream.'-3 t-PA is also released in cultures of various fetal organs.4 Urokinase5 is secreted from the kidneys into the urine.6 It is secreted in kidney cell cultures78 and also in cultures of most human fetal organs. 4 Malignant tumours produce plasminogen activators, and plasminogen activator released from ovarian carcinoma in culture was the first reported to be immunologically identical to urokinase.9 Production of urokinase like plasminogen activators has been found in other tumours as well. '0-'4 In addition, certain melanoma cell lines produce blood tissue like plasminogen activator.'5 t-PA isolated from malignant melanoma cells had provided sufficient amounts of antigen to raise antibodies against t-PA.4
In the present study, using monospecific antibodies againt t-PA and urokinase, we examined the histological localisation of immunoreactive plasminogen activators in skin melanoma and in arteries and veins from human umbilical and peripheral vessels. Accepted '8 Low molecular weight (MW 31 000) and high molecular weight (MW 54 000) urokinase were separated by gel filtration. '9 Antiserum against low molecular weight urokinase was raised in a goat as described for t-PA. IgG from the antiserum was prepared in the same way.
IMMUNOHISTOCHEMISTRY
Phosphate buffered saline (PBS, 0-01 M phosphate, pH 7-4) was used for all washings and sera dilutions. All antisera were diluted in PBS plus 0 25% Triton X-100 and 0 25% bovine serum albumin. Antisera to t-PA were used at dilutions of 1/50 to 1/2000 and urokinase antisera at 1/25 to 1/1000. Control sections were incubated with goat non-immune sera or with PBS only. Endogenous peroxidase activity was minimised by treating the sections before incubation with primary antibody with 0 15% H202 in absolute methanol for 30 min. All sections were rinsed with PBS for 6 h before the first antibody incubation and with PBS plus 0.25% Triton X-100 for 30 (Figs. 3 and 4) . This reaction was restricted to the cytoplasm of the cells. Staining of the surface cells of the umbilical cord was also seen (cf Fig. 9 ), but no other stain reaction was found. We did not find any difference in staining intensity between umbilical cord arterial and venous wall cells. Compared with the umbilical cord vessels, a less intense reaction was obtained in peripheral arteries and veins incubated in parallel with the umbilical cord (cf Fig. 9 ). In these peripheral vessels, both the endothelium and the muscle cells showed a positive t-PA reaction (Figs. 5-8) but only faint staining was seen in sections incubated with antiurokinase (not illustrated).
In frozen sections, incubated for the demonstration of fibrinolytic activity according to Todd, '6 we were unable to find any activity in the umbilical cord. Clearly visible zones of lysis were present in sections of the peripheral vessels, mainly in the adventitia of the vessel walls. A.
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group.bmj.com on October 29, 2017 -Published by http://jcp.bmj.com/ Downloaded from Figs. 1 and 2 Portion ofa malignant melanoma ofskin, composed oflarge, clear epithelioid type ofcells. Section in Fig. 1 was incubated with anti-t-PA 11200. Fig. 2 is the control section incubated with non-immune serum. A brown reaction product indicating the presence oft-PA is clearly seen within the cytoplasm ofthe tumour cells. A brown staining in control sections corresponds to melanin pigment. x400.
Figs. 3 and 4 Portion ofumbilical cord artery, incubated with anti-t-PA 1180 (Fig. 3) . Control section Fig. 4 (see also Fig. 9 ). Clearly positive staining is found in the endothelium and in the muscle cells. A similar degree ofstaining was seen in the umbilical cord vein endothelium and muscle cells. x200.
Figs. 5 and 6 Portion ofperipheral artery, incubated with anti-t-PA 1180 (Fig. 5) . Control section Fig. 6 (see also Fig. 9 ). Positve staining is seen in the endothelium and in the muscle cells, the intensity ofstaining being less than in corresponding umbilical cord arteries (cfFig. 3). x200.
Figs. 7 and 8 Portion ofperipheral vein, incubated with anti-t-PA 1180 (Fig. 7) . Control section Fig. 8 (see also Fig. 9 ). Positive staining is found in the endothelium and in the muscle cells, the intensity being less than in corresponding umbilical cord vein (cfFig. 3). x200. To check the validity of the method and the t-PA antibodies, sections of malignant melanomas were used and the presence of t-PA could be clearly identified (Fig. 1) . The results also show that in veins as well as in the arteries t-PA is found not only in the endothelium but also in the muscle wall. In several studies using the histochemical method of Todd '6 as modified by Pandolfi' fibrinolytic activity of veins was mainly restricted to the adventitia.2930' Abscence of endothelial fibrinolytic activity in these studies and the presence of immunoreactive t-PA in the present study may be explained by recent observations that an inhibitor of t-PA is present and released from endothelial cells. 23128 We could not completely exclude the presence of urokinase in the vessel walls. Using the histochemical technique, Ljungneret a132 found that the activity of t-PA was completely quenched by antibodies against t-PA but unchanged when antibodies against urokinase were mixed in the fibrin film. It is possible that some enzymatically inactive preurokinase33-36 Fig. 9 Cross section ofumbilical cord, with the two arteries (1) and the vein (2), mounted in the same block as a separate peripheral artery (3) and vein (4). In such sections, t-PA reactivity has been recorded in the surface cell layer (arrow), in endothelial cells, and muscle cells ofthe vessel walls, with umbilical cord vessels showing a higher degree of activity than peripheral vessels (cfFigs. 3-8). x20. 144 which possesses immunoreactive properties could be present in the vessel wall. Holmberg et a14, however, found secretion into the medium of t-PA as well as of urokinase in organ culture of various fetal organs, but aorta explants released only t-PA. In cultured human endothelial cells, Levin28 did not find any evidence for secretion of urokinase like plasminogen activator.
The method and the results presented here might prove useful for selection of cell structures for culture and production of t-PA and also for experimental studies of t-PA activity in physiological and pathological processes.
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